November 05, 2025
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
Dr Sys Dr Sys
top
Dr Sys
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
Menu
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
loading...
Latest Blogs
  • Todd Crisley explains why he is “not interested” in sitting with his separated daughter from LindsayTodd
  • After being ravaged by the delta Covid variant, how is India doing now?
  • Putin reveals he had the Sputnik Covid shot as Russia struggles with its vaccine uptake
  • Novartis prostate cancer drug receives FDA breakthrough designation
  • Vaccination may ease symptoms of long COVID
  • UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns
  • Pfizer, BioNTech request expanded emergency use of Covid-19 vaccine for ages 12-15
  • France widens COVID-19 restrictions, orders schools closed as virus cases surge
  • Johnson & Johnson’s one-shot Covid vaccine cleared for use in the EU
  • FDA staff endorses J&J’s single-shot Covid vaccine for emergency use — clearing way for third vaccine in U.S.
Home SCIENCE
Putin reveals he had the Sputnik Covid shot as Russia struggles with its vaccine uptake

Putin reveals he had the Sputnik Covid shot as Russia struggles with its vaccine uptake

Russian President Vladimir Putin said Wednesday that he had received the Sputnik V coronavirus vaccine, as the...

Novartis prostate cancer drug receives FDA breakthrough designation

Novartis prostate cancer drug receives FDA breakthrough designation

Swiss drugmaker Novartis has received breakthrough therapy designation from the U.S. Food and Drug Administrat...

UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns

UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns

People under the age of 40 in the U.K. are to be offered an alternative to the Oxford-AstraZeneca Covid-19 vac...

FDA staff endorses J&J’s single-shot Covid vaccine for emergency use — clearing way for third vaccine in U.S.

FDA staff endorses J&J’s single-shot Covid vaccine for emergency use — clearing way for third vaccine in U.S.

The Food and Drug Administration’s staff endorsed Johnson & Johnson’s Covid-19 vaccine for emergency use,...

Crain’s Health Pulse New York: Virtual Reality, Hybrid Instruction Enliven Medical Education During Pandemic

Crain’s Health Pulse New York: Virtual Reality, Hybrid Instruction Enliven Medical Education During Pandemic

Medical schools across the country have adjusted their curriculums in the wake of coronavirus disease (COVID-1...

Google launches knowledge panels in search results to tackle misinformation about Covid vaccines

Google launches knowledge panels in search results to tackle misinformation about Covid vaccines

If you are looking to open an offshore branch of your corporation or are a well-off individual who wants their...

Smell training could help overcome odor distortions after COVID-19, shows study

Smell training could help overcome odor distortions after COVID-19, shows study

If you’ve been experiencing odor distortions after Covid-19, then ‘smell training’ could hel...

Cancer research breakthrough: Scientists discover test predicting response to immunotherapy

Cancer research breakthrough: Scientists discover test predicting response to immunotherapy

Posted By: Editorial Teamon: November 27, 2018In: SCIENCE, TECHNOLOGYNo Comments

SCIENTISTS in Barcelona have found a tumour marker which predicts how cancer cells will respond to immunotherapy treatment – hailed as the future of oncology medication. The report, published in Annals of Oncology and carried out by the Pi and Sunyer Institute of Biomedical Research (IDIBAPS) based at Barcelona’s Hospital Clínic, says the higher the […] Read more

Share 0
Tweet
Share
Share
Share
Spanish scientists challenge origins of Parkinson's

Spanish scientists challenge origins of Parkinson’s

Posted By: Editorial Teamon: November 27, 2018In: SCIENCENo Comments

SCIENTISTS at a Madrid neurobiology laboratory have made a ground-breaking discovery as to the origins of Parkinson’s disease, throwing into conjecture previous assumptions about where the condition starts. The HM CINAC, or Integral Centre for Neurosciences, says the disease may not, in fact, ‘spread’ to the cerebral cortex as its ‘final destination’, as has hitherto […] Read more

Share 0
Tweet
Share
Share
Share
More Valsartan blood-pressure drugs taken off sale

More Valsartan blood-pressure drugs taken off sale

Posted By: Editorial Teamon: November 27, 2018In: SCIENCE, TECHNOLOGYNo Comments

MORE batches of the high blood pressure drug Valsartan have been taken off the shelves after tests revealed the presence of N-Nitrosodimethylamine (NDMA), a substance which could be cancerous, in some samples. Changes in the manufacturing process at the Zhejiang Huahai Pharmaceutical laboratory in China – authorised by the European Directorate of Quality in Medications […] Read more

Share 0
Tweet
Share
Share
Share
12345

Advertising

services
solutions
vrp

2018 Powered By GroupW

  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
 

Loading Comments...